… a dynamic process similar to atherosclerosis. Endothelial cell dysfunction followed by
subendothelial accumulation of lipoproteins and chronic inflammation results in a condition that …

… Apolipoprotein AI (ApoA-I), the major protein component of high density lipoprotein (HDL), …
In addition, by using a murine model of atherosclerosis, it was shown that myeloid Abca1/g1 …

… of the apoB containing lipoproteins in one number … function (eg cholesterol efflux capacity).
Furthermore, we describe many beneficial properties of HDL that antagonize atherosclerosis …

… Lp(a) has many functions, which include proatherosclerotic, prothrombotic and pro-inflammatory
roles. Here, we review recent data on the role of Lp(a) in the atherosclerotic process, …

… lipoprotein cholesterol. Thus, current understanding of the inflammatory mechanisms of
atherosclerosis … incident lung cancer and lung cancer mortality, although lung cancer was not a …

… the inflammation hypothesis of atherosclerosis in humans required a trial with an intervention
that reduced inflammation but did not alter atherogenic lipoproteins. … A decrease in cancer …

… The oxidized LDL portion is avidly taken up by macrophages to generate foam cells and
promote atherosclerotic plaque formation. Lp(a) is the only apoB-containing lipoprotein that …

… Crohn's disease, diabetes multiple sclerosis, breast cancer and Alzheimer's disease [34].
Advanced human atherosclerotic plaques demonstrated that the autophagy protein ATG16L1 …

… Elevated circulating concentrations of lipoprotein(a) [Lp(a)] is strongly associated with
increased risk of atherosclerotic cardiovascular disease (CVD) and degenerative aortic stenosis. …

… Its accumulation in the vasculature causes plaque formation and atherosclerosis, kidney
disease, and cancer. Several studies show that many oncogenic signaling pathways modulate …